Metraipolis › archive › dc_9832086cb42f

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model — Europe PMC PMID:28843257

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28843257
DOI
10.22034/apjcp.2017.18.8.2209
License (as archived)
solo-consultazione
Archived
2026-11-08T14:02:01.464Z
SHA-256 of the archived text
d3398c39234fe365e3bb895015785ffe7c8e74152f96a020942448f0fe662eae
Stable URL of this page
https://metraipolis.com/documento/dc_9832086cb42f

How to cite

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model — Europe PMC PMID:28843257 — Europe PMC (en), https://europepmc.org/article/MED/28843257 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9832086cb42f (Metraipolis archive dc_9832086cb42f, sha256 d3398c39234fe365e3bb895015785ffe7c8e74152f96a020942448f0fe662eae)
BibTeX
@misc{dc9832086cb42f,
  title = {BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model — Europe PMC PMID:28843257},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28843257},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9832086cb42f; sha256 d3398c39234fe365e3bb895015785ffe7c8e74152f96a020942448f0fe662eae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28843257. Agents can read the archived copy with the MCP tool read_document.